3P Learning (ASX:3PL) must arrest school churn to protect its valuation
3P Learning (ASX: 3PL)’s valuation now hinges on whether the business review can arrest B2B school churn and declining revenue before the longer-term value in Reading Eggs, Mathletics and its expanding US homeschool channel is eroded. The urgency is clear from the half-year result: revenue fell to $51.9m and underlying EBITDAA to $5.7m, prompting management to launch a strategic reset focused on cash generation, stronger positions in target markets and a more profitable operating model.
The key question: whether 3P Learning can convert its core growth assets into visible, sustainable cash flow before operating pressure overwhelms the story.
Against that, the company still has recognised education brands, recurring subscription revenue, $7.5m of net cash and no debt, leaving investors to judge whether this is a fixable execution problem or a sign the core school model is losing relevance.
What are the Best ASX Stocks to invest in right now?
Check our buy/sell tips
The business review now drives valuation, not user growth
3P Learning’s key valuation driver is no longer simple user growth but the outcome of the business review launched with its half-year result on 24 February. That decision matters because management is reshaping the company around cash generation, stronger positions in target markets and a more profitable operating model after a period of declining revenue and elevated churn.
The numbers explain the urgency. First-half FY26 revenue fell to $51.9m and underlying EBITDAA came in at $5.7m, showing the core school business is not yet producing reliable growth. Yet the same result also showed statutory NPAT of $0.4m, net cash of $7.5m and no external borrowings, giving management room to act.
For investors, the tension is clear: 3P Learning still owns recognised education brands and recurring subscription revenue, but valuation support now depends on proving those assets can grow without sacrificing margins.
The market is balancing weaker growth against improving cash discipline
Over the past year, the share price context has been shaped by softer operating momentum alongside signs of better cash discipline. The most important announcement was the February FY26 guidance, which pointed to full-year revenue of $105m to $107m, underlying EBITDA of $13m to $15m and net cash of $16m to $18m.
That guidance framed the debate around whether lower growth can be offset by stronger conversion of earnings into cash. A second development added pressure when S&P Dow Jones Indices said 3P Learning would be removed from the All Ordinaries before the open on 23 March.
This does not change the company’s economics, but it can affect short-term trading and sentiment. Investors are now weighing whether the current share price reflects a temporary de-rating or a more structural reassessment of the business model.
Subscription economics remain central to the investment case
3P Learning generates revenue from online education subscriptions sold to schools and parents. Its key products include Reading Eggs, Mathseeds, Mathletics and Writing Legends, supported by assessment tools, reporting dashboards and bundled offerings such as 3 Essentials.
This matters because subscription software can deliver recurring revenue, high customer lifetime value and a more predictable earnings base than one-off content sales.
The split between B2B schools and B2C parents is central. School licences provide scale and embedded usage, while parent subscriptions offer a direct growth channel, particularly in homeschool markets.
School churn is the structural issue the market is pricing
The current share price appears to reflect a structural challenge in the school channel rather than a single weak period. Management has pointed to a tougher post-COVID B2B environment, where churn in existing school customers offsets gains from new sales.
At the same time, recent updates showed positive indicators. Homeschool Max in the US has generated consistent revenue, ESA vendor approval has expanded to 13 states covering more than 800,000 eligible students, and US schools delivered double-digit growth in new business billings including 21 new districts.
These indicators point to demand, but investors are distinguishing between pipeline strength and realised financial outcomes. Growth only matters if it converts into net revenue after churn while preserving margins.
US execution and retention will determine whether growth is credible
The single most important valuation driver is whether 3P Learning can translate its US opportunity into repeatable net growth while reducing B2B churn. The bullish case depends on ESA-funded homeschool demand expanding, stronger conversion of district pipelines and improved retention from bundled product offerings.
If those factors align, the company may be re-rated as a cash-generative software business with a credible second growth leg rather than a mature asset in decline.
The conditions for that re-rating are clear. The company must meet FY26 guidance, deliver the expected uplift in EBITDA and net cash, and ensure the business review simplifies rather than complicates the operating model.
Execution will determine whether upside can be realised
There is a clear upside case, but it depends on execution. 3P Learning has recognised brands, recurring revenue, no debt and guidance pointing to stronger year-end cash.
The downside is equally clear. B2B churn could continue to offset new sales, US pipeline conversion may disappoint, B2C margins could remain under pressure, and competitive or AI-driven demands may require stronger product integration and outcomes data.
The next few months should determine whether the company is fixing its core engine or simply preserving cash while revenue continues to drift.
Blog Categories
Get the Latest Insider Trades on ASX!
Recent Posts
AMA Group (ASX:AMA) recovery is now being tested by whether cash flow can sustain the turnaround
AMA Group (ASX: AMA)’s recovery story is now being tested by whether improving earnings can translate into durable cash flow…
Radiopharm Theranostics (ASX: RAD) is increasingly defined by whether RAD101 can justify a registrational pathway
Radiopharm Theranostics (ASX:RAD) is increasingly defined by whether its lead imaging asset RAD101 can convert encouraging mid-stage data into a…
IperionX (ASX: IPX) needs repeat Virginia orders to unlock its titanium platform value
IperionX (ASX: IPX) is now a trade-off between the cash-hungry ramp-up at its Virginia Titanium Manufacturing Campus and the longer-term…